ARCHIVES

Faulding, NaPro In Agreement For Marketing Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

ACS announces 415 New Awards

August 31, 1979

NIH Review Division Considering Proposal For Clinical Oncology Study Section

October 10, 1997

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

June 23, 2000

Flood Asks ACCC for Greater Community Effort

February 14, 1975

Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen

December 31, 2004